North America In-Vitro Diagnostics Market Growth Drivers and Forecast by 2030
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis by Product and Services (Reagents and Kits, Instruments, and Software and Services), Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation and Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Home Care, and Others)
- Status : Published
- Report Code : TIPRE00022125
- Category : Life Sciences
- No. of Pages : 201
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Services, Technology, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Canada, Mexico, United States
Frequently Asked Questions
The North America in-vitro diagnostics market, based on technology, is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation and hemostasis, hematology, urinalysis, and others. The immunoassay/immunochemistry segment held the largest market share in 2022. However, the molecular diagnostics segment is anticipated to register the highest CAGR during the forecast period.
The North America in-vitro diagnostics market was valued at US$ 56,890.44 million in 2022.
The North America in-vitro diagnostics market is expected to be valued at US$ 78,479.05 million in 2028.
The North America in-vitro diagnostics market majorly consists of the players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corp, Siemens AG, Sysmex Corp, Thermo Fisher Scientific Inc, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, and Qiagen NV.
In-vitro diagnostics can detect diseases or other conditions and can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Devices can range from simple tests to sophisticated DNA technology which include reagents, control materials, calibrators, kits, software, and related instruments. In-vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America In-Vitro Diagnostics Market – by Product and Services
1.3.2 North America In-Vitro Diagnostics Market – by Technology
1.3.3 North America In-Vitro Diagnostics Market – by Application
1.3.4 North America In-Vitro Diagnostics Market – by End User
1.3.5 North America In-Vitro Diagnostics Market – by Country
2. North America In-Vitro Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In-Vitro Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 NORTH AMERICA – PEST Analysis
4.3 Expert Opinion
4.4 Regulatory Scenario
4.4.1 FDA IVD Regulation
4.4.2 LDT
4.4.3 RUO
5. In-Vitro Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Rise in the Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraints
5.2.1 Cumbersome Reimbursement Procedures and Stringent Regulations Regarding Product Approvals
5.3 Market Opportunities
5.3.1 Integration of IVD Technologies with Digital Health Solutions
5.4 Impact analysis
6. North America In-Vitro Diagnostics Market Analysis
6.1 North America In-Vitro Diagnostics Market Revenue Forecast and Analysis
6.1.1 Market Positioning of Key Players in In-Vitro Diagnostics Market
7. North America In-Vitro Diagnostics Market Analysis – by Products and Services
7.1 Overview
7.2 Reagents and Kits
7.2.1 Overview
7.2.2 Reagents and Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Software and Services
7.4.1 Overview
7.4.2 Software and Services: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. North America In-Vitro Diagnostics Market Analysis – by Technology
8.1 Overview
8.2 Immunoassay/Immunochemistry
8.2.1 Overview
8.2.2 Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Clinical Chemistry
8.3.1 Overview
8.3.2 Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Molecular Diagnostics
8.4.1 Overview
8.4.2 Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Microbiology
8.5.1 Overview
8.5.2 Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Blood Glucose Self-Monitoring
8.6.1 Overview
8.6.2 Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Coagulation and Hemostasis
8.7.1 Overview
8.7.2 Coagulation and Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Hematology
8.8.1 Overview
8.8.2 Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Urinalysis
8.9.1 Overview
8.9.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. North America In-Vitro Diagnostics Market Analysis – by Application
9.1 Overview
9.2 Infectious Disease
9.2.1 Overview
9.2.2 Infectious Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Diabetes
9.3.1 Overview
9.3.2 Diabetes: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Autoimmune Disease
9.6.1 Overview
9.6.2 Autoimmune Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Nephrology
9.7.1 Overview
9.7.2 Nephrology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. North America In-Vitro Diagnostics Market Analysis – by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Laboratories
10.3.1 Overview
10.3.2 Laboratories: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Homecare
10.4.1 Overview
10.4.2 Homecare: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. North America In-Vitro Diagnostics Market – Regional Analysis
11.1 North America In-Vitro Diagnostics Market
11.1.1 Overview
11.1.2 North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.6.1 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.1 Overview
11.1.6.1.2 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.6.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.6.1.5 US: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6.1.6 US: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.6.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.1 Overview
11.1.6.2.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.6.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.6.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.6.3 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.1 Overview
11.1.6.3.2 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.6.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.6.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
12. Pre and Post Covid-19 Impact on North America In-Vitro Diagnostics Market
12.1 Pre and Post Covid-19 Impact
13. North America In-Vitro Diagnostics Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies in North America In-Vitro Diagnostics Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. Hoffmann-La Roche Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Danaher Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Siemens AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sysmex Corp
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Becton Dickinson and Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Bio-Rad Laboratories Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Qiagen NV
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 2. North America: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. US: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 6. US: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. US: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 8. US: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Recent Organic Growth Strategies in North America In-Vitro Diagnostics Market
Table 18. Recent Inorganic Growth Strategies in the North America In-Vitro Diagnostics Market
Table 19. Glossary of Terms, North America In-Vitro Diagnostics Market
LIST OF FIGURES
Figure 1. In-Vitro Diagnostics Tube Market Segmentation
Figure 2. In-Vitro Diagnostics Market Segmentation, by Country
Figure 3. North America In-Vitro Diagnostics Market Overview
Figure 4. Reagents and Kits Held Largest Share of Product and Services Segment in In-Vitro Diagnostics Market
Figure 5. North America In-Vitro Diagnostics Market – Leading Country Markets (US$ Million)
Figure 6. North America In-Vitro Diagnostics Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. North America In-Vitro Diagnostics Market – Revenue Forecast and Analysis – 2020–2030
Figure 10. North America In-Vitro Diagnostics Market, by Products and Services, 2022 & 2030 (%)
Figure 11. Reagents and Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Software and Services: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. North America In-Vitro Diagnostics Market, by Technology, 2022 & 2030 (%)
Figure 15. Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Coagulation and Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America In-Vitro Diagnostics Market, by Application, 2022 & 2030 (%)
Figure 25. Infectious Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diabetes: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Oncology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Cardiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Autoimmune Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Nephrology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. North America In-Vitro Diagnostics Market, by Application, 2022 & 2030 (%)
Figure 33. Hospitals: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Laboratories: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Homecare: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. North America In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. North America In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 40. US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Pre and Post Covid-19 Impact on In-Vitro Diagnostics Market in North America
Figure 44. Growth Strategies in North America In-Vitro Diagnostics Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For